Condition: Systemic Lupus Erythematosus (SLE) · Cutaneous Lupus Erythematosus (CLE) · Sponsor: EMD Serono Research & Development Institute, Inc.
The purpose of this global, multicenter, Phase 3 study is to evaluate the efficacy and safety of enpatoran over 24 weeks in participants with active cutaneous manifestations of lupus erythematosus with or without systemic disease. Study details include: Study Duration: Up to 35 weeks. Treatment Duration: 24 weeks. Visit Frequency: every 4 weeks, with the exception of the Week 2 televisit. Study Intervention Name: Enpatoran, Placebo. Intervention Form: Film-coated tablet.
This description comes directly from the study's public registry record.
Communication Center · +49 6151 72 5200 · service@emdgroup.com
Always discuss trial participation with your own doctor first.
| Dermatology Research Associates - 300204025 | Los Angeles, California, United States | Recruiting |
| Cohen Medical Centers | Thousand Oaks, California, United States | Recruiting |
| GNP Research at Mark Jaffe, MD | Cooper City, Florida, United States | Recruiting |
| Advance Medical Research Center | Miami, Florida, United States | Recruiting |
| Diverse Clinical Research LLC | Miami, Florida, United States | Recruiting |
| D&H National Research Centers, Inc. | Tamarac, Florida, United States | Recruiting |
| Clinical Research of West Florida, Inc. | Tampa, Florida, United States | Recruiting |
| Emory University School of Medicine | Atlanta, Georgia, United States | Recruiting |
| Revival Research Institute, LLC | Troy, Michigan, United States | Recruiting |
| Allen Arthritis | Allen, Texas, United States | Recruiting |
| Arthritis and Rheumatology Research Institute PLLC | Allen, Texas, United States | Recruiting |
| Arthritis Care of Texas | Corpus Christi, Texas, United States | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07332481